M. E. Lebsack
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Antibiotic Resistance in Bacteria 2
- Co-authors
- G. Campion (1 shared paper)Janice L. Lookabaugh (1 shared paper)Gary V. Gordon (1 shared paper)Roberta Hanna (1 shared paper)Joan Korth‐Bradley (1 shared paper)Abbe Rubin (1 shared paper)Donna Simcoe (1 shared paper)Allen J. Sedman (6 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Clinical Oncology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Annals of Pharmacotherapy (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
M. E. Lebsack
10 papers receiving 425 citations
Peers
Comparison fields: 5 of 68
- Rheumatology 160
- Hematology 81
- Pharmacology 86
- Molecular Medicine 26
- Immunology 93
Countries citing papers authored by M. E. Lebsack
This map shows the geographic impact of M. E. Lebsack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Lebsack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Lebsack more than expected).
Fields of papers citing papers by M. E. Lebsack
This network shows the impact of papers produced by M. E. Lebsack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Lebsack. The network helps show where M. E. Lebsack may publish in the future.
Co-authors
The 25 scholars most cited alongside M. E. Lebsack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 197 | |
| 2 | 2000 | 118 | |
| 3 | 1989 | 85 | |
| 4 | 1992 | 25 | |
| 5 | Safety of FLT3 ligand in healthy volunteers | 1997 | 15 |
| 6 | 1996 | 9 | |
| 7 | 1988 | 5 | |
| 8 | 1993 | 5 | |
| 9 | 1992 | 2 | |
| 10 | 1991 | 2 |
About M. E. Lebsack
M. E. Lebsack is a scholar working on Pharmacology, Pharmacology, Molecular Medicine, Emergency Medicine and Analytical Chemistry, having authored 10 papers that have together received 463 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Resistance in Bacteria (2 papers), Poisoning and overdose treatments (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Cancer therapeutics and mechanisms (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Acute Myeloid Leukemia Research (1 paper) and Advanced Drug Delivery Systems (1 paper). The work is most often cited by research in Rheumatology (160 citations), Hematology (81 citations), Pharmacology (86 citations), Molecular Medicine (26 citations) and Immunology (93 citations). M. E. Lebsack has collaborated with scholars based in United States and Canada. Frequent co-authors include G. Campion, Janice L. Lookabaugh, Gary V. Gordon, Roberta Hanna, Joan Korth‐Bradley, Abbe Rubin, Donna Simcoe, Allen J. Sedman, Jerome J. Schentag and Thaddeus H. Grasela. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics and Annals of Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.